Cochrane review: only weak evidence supports tramadol for cancer pain

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • There is only limited, very low quality evidence favoring tramadol (Ultram) for cancer pain.
  • There are no studies of tramadol's analgesic effects in children with cancer.
Why this matters
  • The Cochrane review concludes that the current place of tramadol as step 2 in the World Health Organ...